Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Polygenic Assessment and Autoimmunity Testing for Health-System Screening of Type 1 Diabetes (PATHS-T1D)

NCT07802496 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07802496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07802496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Polygenic Assessment and Autoimmunity Testing for Health-System Screening of Type 1 Diabetes (PATHS-T1D)
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
October 15, 2026
Completion date
October 1, 2030
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes